Clinical Trial Update: A Phase 1 Study To Estimate The Effects Of PD 0332334 On Lithium Pharmacokinetics In Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study to estimate the effect of PD 0332334 on lithium pharmacokinetics in healthy subjects has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• PD 0332334

Snippet

Sponsor: Pfizer | Conditions: Generalized Anxiety Disease | Phase 1 | Status: WITHDRAWN